JournalsHub
.online
Find My Journal
JC

Joel Charrow

Northwestern University US

241
Publications
12,164
Citations
57
H-Index
121
i10-Index
2.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

240 total

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat PDF

Dominique P. Germain, Derralynn Hughes, Kathy Nicholls, Daniel G. Bichet, Roberto Giugliani et al. - New England Journal of Medicine, 2016
Cited by 548 OpenAlex

Vosoritide (BMN 111) in Children with Achondroplasia: Initial results from a Phase 2, open-label, sequential cohort, dose-escalation study

A. Sagar, Irving Melita, B. Carlos, Cao Xiaofan, C. Joel - Unknown Venue, 2016
Cited by 0 Semantic Scholar

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease PDF

Dominique P. Germain, Joel Charrow, Robert J. Desnick, Nathalie Guffon, Judy Kempf et al. - Journal of Medical Genetics, 2015
Cited by 358 OpenAlex

Approach to management of cross-reactive immunologic material (CRIM)-negative infantile pompe patients treated with ERT: Role of immune modulation in changing the natural history

S. Banugaria, Sean N. Prater, Trusha Patel, Stephanie M. Dearmey, C. Milleson - Unknown Venue, 2013
Cited by 1 Semantic Scholar

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease

Dominique P. Germain, Stephen Waldek, Maryam Banikazemi, David A. Bushinsky, Joel Charrow et al. - Journal of the American Society of Nephrology, 2007
Cited by 435 OpenAlex

Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry

Christine M. Eng, Janice M. Fletcher, William R. Wilcox, Stephen Waldek, C. Ronald Scott et al. - Journal of Inherited Metabolic Disease, 2007
Cited by 384 OpenAlex

A rational approach for a phase I clinical study design to evaluate CNTO 95, a novel, fully human anti-avmonoclonal antibody (MAb), in patients with solid tumors.

H. Davis, U. Prabhakar, H. Jang, Q. Jiao, M. Trikha - Journal of Clinical Oncology, 2004
Cited by 3 Semantic Scholar

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

Neal J. Weinreb, Joel Charrow, Hans C. Andersson, Paige Kaplan, Edwin H. Kolodny et al. - The American Journal of Medicine, 2002
Cited by 541 OpenAlex

The Gaucher Registry

Joel Charrow, Hans C. Andersson, Paige Kaplan, Edwin H. Kolodny, Pramod K. Mistry et al. - Archives of Internal Medicine, 2000
Cited by 583 OpenAlex

Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study

Robert Listernick, Joel Charrow, Mark J. Greenwald, Marilyn B. Mets - The Journal of Pediatrics, 1994
Cited by 546 OpenAlex

Research Topics

Lysosomal Storage Disorders Research (92) Neurofibromatosis and Schwannoma Cases (35) Carbohydrate Chemistry and Synthesis (26) Connective tissue disorders research (26) Glycosylation and Glycoproteins Research (24)

Affiliations

Northwestern University
US 2026 - 1983
Children's Hospital of Wisconsin
US 1989 - 1989
University of Maryland, Baltimore
US 1983 - 1983
Lurie Children's Hospital
US 2025 - 1981
Royal Children's Hospital
AU 2019 - 2019

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now